Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Microfluidic double emulsion and particle for a controlled release of therapeutic peptide

4th International Conference on Advances in Biotechnology and Bioscience

Marine Truchet

ESPCI, France

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C6-103

Abstract
Encapsulation of peptide therapeutics has a growing significance in pharmaceutical and biotech industry to control the release over weeks or months. If the capsule is made from biodegradable polymer, it will degrade slowly and release the drug progressive. To fabricate the particle, people often use the double emulsion/solvent removal method. A double emulsion of water in oil in water (W/O/W) is formed. The active ingredient is within the inner water droplet. The middle phase composed of the solvent and the biodegradable polymer is then solidified. The emulsification process is mostly performed with mechanical stirring or ultrasonication, a process that enables the creation of large volumes of emulsions but results in very bad monodispersity and low encapsulation yield. The production of monodispersed (W/O/W) double emulsions using different microfluidics technologies has been demonstrated. However, none of them could be used to prepare microparticles with desired properties compatible with control delivery of APIs. Each technique has one or several limitations: compatibility of chips with solvents, low throughput, droplet size. In this study, we solved these problems by combining traditional technologies with microfluidics. Our three-step hybrid process allows the formation of very well controlled size, morphology and drug loading particles. We managed, for the first time, to obtain micro-particles with desired particle size, whose structure is controlled and adapted to the delivery challenge we address. We are now able to study precisely the mechanism of release and the influence of each parameter on the drug release. Recent Publications 1. Bezemer J M et al. (2000) Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. Journal of Controlled Release. 67(2-3):233-248. 2. S Okushima et al. (2004) Controlled production of monodisperse double emulsions by two-step droplet breakup in microfluidic devices. Langmuir 20(23):9905-8. 3. Utada A S et al. (2005) Monodisperse double emulsions generated from a microcapillary device. Science 308(5721):537- 41. 4. J Pessi et al. (2014) Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery. International Journal of Pharmaceutics 472(1-2):82-87.
Biography

Marine Truchet is currently a third year PhD student at ESPCI, Paris, France. She pursued her Engineering Diploma from Centrale Nates and an 8-month internship in a biotechnological start-up, Twist Bioscience. This experiment permits her to discover microfluids and to acquire strong knowledge in biotechnology. Her PhD project is in collaboration with the Gulliver Laboratory at ESPCI and the pharmaceutical company SANOFI.

E-mail: marine.truchet@espci.fr

 

Top